By reversing p-glycoprotein-mediated resistance, it can be used as a research direction for chemotherapeutic drug sensitizers and provide a safe and effective strategy for treating tumor cells that develop resistance to drugs. The gene discussed is ABCB1; the disease is neoplasm.